It's apparent that the work done in the medical field is going to be some of the most extensive you can imagine. Mice are commonly utilized in terms of testing out new drugs, which works well before certain drugs are administered to patients. It's good to know that they aren't going to be harmful and that there will be much stronger results in due time. Brain tumor research seems to follow this same kind of process, as evidenced by a recent story that has rightfully seized my attention.
According to Science Daily, John Hopkins researchers have been working hard to see how mice react to a certain FDA-approved drug. However, in order to make this viable in the field of brain tumor research, the mice were treated as they had human tumor cells in their bodies. What's even more interesting than this is that the drug showed a halting of such tumors and there was no trace to be found as well. To say that this story deserves the attention of organizations like Voices against Brain Cancer would be an understatement.
The story went into detail about a mutation that was spotted within the IDH1 gene in 2008. For those who do not know what this gene entails, it is a rather common element that has been seen in about 70 to 80 percent of lower-grade tumors. With this mutation, the brain has difficulty bringing glucose into effect, transitioning it to an energy form so that the body can utilize it. It's apparent that there are challenges when you're talking about this field in particular and it's not hard to see why.
It appears as though a number of different types of tumors are going to be focused on, which should be brought into account for every case. Not every growth is going to be the same, especially when you take into account all of the intricacies that one particular growth may have as opposed to another. Gliomas, for example, may be some of the most typical but does this necessarily mean that this one alone is going to be focused on? You will start to see many more in the medical field soon enough.
As more and more work is done in the name of brain tumor research, I have to believe that further cures can be found on the matter. This type of research, in my opinion, is one of the most extensive and you have to look into the intricate nature of these tumors as the reason for it. However, knowing that there has been success with this particular trial goes to show that there is a chance for humans to benefit from it. From what I've learned, it's just going to take time.
According to Science Daily, John Hopkins researchers have been working hard to see how mice react to a certain FDA-approved drug. However, in order to make this viable in the field of brain tumor research, the mice were treated as they had human tumor cells in their bodies. What's even more interesting than this is that the drug showed a halting of such tumors and there was no trace to be found as well. To say that this story deserves the attention of organizations like Voices against Brain Cancer would be an understatement.
The story went into detail about a mutation that was spotted within the IDH1 gene in 2008. For those who do not know what this gene entails, it is a rather common element that has been seen in about 70 to 80 percent of lower-grade tumors. With this mutation, the brain has difficulty bringing glucose into effect, transitioning it to an energy form so that the body can utilize it. It's apparent that there are challenges when you're talking about this field in particular and it's not hard to see why.
It appears as though a number of different types of tumors are going to be focused on, which should be brought into account for every case. Not every growth is going to be the same, especially when you take into account all of the intricacies that one particular growth may have as opposed to another. Gliomas, for example, may be some of the most typical but does this necessarily mean that this one alone is going to be focused on? You will start to see many more in the medical field soon enough.
As more and more work is done in the name of brain tumor research, I have to believe that further cures can be found on the matter. This type of research, in my opinion, is one of the most extensive and you have to look into the intricate nature of these tumors as the reason for it. However, knowing that there has been success with this particular trial goes to show that there is a chance for humans to benefit from it. From what I've learned, it's just going to take time.
About the Author:
Contact Voices Against Brain Cancer if you're seeking more information about glioblastoma research.
0 comments:
Post a Comment